65.22
price up icon2.62%   1.665
after-market Dopo l'orario di chiusura: 66.81 1.595 +2.45%
loading
Precedente Chiudi:
$63.55
Aprire:
$63.76
Volume 24 ore:
639.59K
Relative Volume:
0.92
Capitalizzazione di mercato:
$1.65B
Reddito:
$56.54M
Utile/perdita netta:
$-30.70M
Rapporto P/E:
-167.22
EPS:
-0.39
Flusso di cassa netto:
$-31.05M
1 W Prestazione:
+5.19%
1M Prestazione:
+26.64%
6M Prestazione:
+172.41%
1 anno Prestazione:
+415.94%
Intervallo 1D:
Value
$62.15
$66.20
Intervallo di 1 settimana:
Value
$60.30
$66.20
Portata 52W:
Value
$10.14
$66.94

Cidara Therapeutics Inc Stock (CDTX) Company Profile

Name
Nome
Cidara Therapeutics Inc
Name
Telefono
858-752-6170
Name
Indirizzo
6310 NANCY RIDGE DRIVE, SAN DIEGO, CA
Name
Dipendente
73
Name
Cinguettio
@CidaraThera
Name
Prossima data di guadagno
2024-10-31
Name
Ultimi documenti SEC
Name
CDTX's Discussions on Twitter

Confronta CDTX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CDTX
Cidara Therapeutics Inc
65.22 1.61B 56.54M -30.70M -31.05M -0.39
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
392.79 100.07B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
580.41 59.99B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
448.91 58.03B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
653.83 39.93B 3.06B 1.28B -614.78M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
321.36 36.82B 3.81B -644.79M -669.77M -6.24

Cidara Therapeutics Inc Stock (CDTX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-18 Ripresa H.C. Wainwright Buy
2025-03-12 Iniziato Citizens JMP Mkt Outperform
2025-01-27 Ripresa Cantor Fitzgerald Overweight
2024-12-13 Iniziato RBC Capital Mkts Outperform
2024-11-08 Iniziato Guggenheim Buy
2024-08-14 Aggiornamento H.C. Wainwright Neutral → Buy
2021-12-03 Ripresa H.C. Wainwright Buy
2021-09-22 Aggiornamento WBB Securities Buy → Strong Buy
2021-03-04 Iniziato Aegis Capital Buy
2019-09-04 Aggiornamento Wedbush Neutral → Outperform
2018-07-26 Iniziato Citigroup Buy
2017-04-21 Iniziato Raymond James Strong Buy
2017-04-17 Reiterato H.C. Wainwright Buy
2017-04-12 Iniziato Ladenburg Thalmann Buy
2017-04-11 Ripresa Wedbush Outperform
2017-02-22 Reiterato H.C. Wainwright Buy
2017-02-22 Aggiornamento WBB Securities Sell → Hold
2016-12-21 Ripresa Leerink Partners Outperform
2016-12-19 Iniziato H.C. Wainwright Buy
2016-09-23 Downgrade WBB Securities Hold → Sell
2015-10-09 Aggiornamento WBB Securities Sell → Hold
2015-05-11 Iniziato Jefferies Buy
2015-05-11 Iniziato Leerink Partners Outperform
2015-05-11 Iniziato Needham Buy
2015-05-11 Iniziato Wedbush Outperform
2015-04-23 Iniziato WBB Securities Sell
Mostra tutto

Cidara Therapeutics Inc Borsa (CDTX) Ultime notizie

pulisher
01:20 AM

Cidara Therapeutics: A High-Conviction Biotech Play with Clear Path to FDA Phase 3 and Market Disruption - AInvest

01:20 AM
pulisher
01:07 AM

Cidara Therapeutics: Still Big Catalysts Ahead Following Impressive Ph2b Readout (CDTX) - Seeking Alpha

01:07 AM
pulisher
10:06 AM

Cidara Therapeutics: Promising Trials Amidst Financial Challenges - MSN

10:06 AM
pulisher
09:32 AM

Fund Update: MORGAN STANLEY added 875,198 shares of CIDARA THERAPEUTICS (CDTX) to their portfolio - Quiver Quantitative

09:32 AM
pulisher
Aug 14, 2025

Cidara Therapeutics, Inc. (NASDAQ:CDTX) Q2 2025 Earnings Call Transcript - MSN

Aug 14, 2025
pulisher
Aug 13, 2025

Cidara (CDTX) Q2 Cash Surges 163% - AOL.com

Aug 13, 2025
pulisher
Aug 12, 2025

Cidara Therapeutics Inc. Pullback Analyzed — Is It Time to ExitMarket Entry and Exit Point Tips From Traders - beatles.ru

Aug 12, 2025
pulisher
Aug 09, 2025

A Quick Look at Today's Ratings for Cidara Therapeutics(CDTX.US), With a Forecast Between $66 to $74 - 富途牛牛

Aug 09, 2025
pulisher
Aug 08, 2025

Cidara Therapeutics 2024 Q2 Earnings Net Loss Widens by 569.5% - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Cidara Therapeutics price target raised to $74 from $54 at Needham - TipRanks

Aug 08, 2025
pulisher
Aug 08, 2025

Guggenheim raises Cidara Therapeutics stock price target to $70 on FDA meeting progress - Investing.com Canada

Aug 08, 2025
pulisher
Aug 08, 2025

Cidara Therapeutics Rallies On Promising Flu Drug Progress - Finimize

Aug 08, 2025
pulisher
Aug 08, 2025

Cidara Therapeutics Reports Positive Trial Results and Financial Growth - TipRanks

Aug 08, 2025
pulisher
Aug 08, 2025

Earnings call transcript: Sidera Therapeutics’ Q2 2025 innovation focus - Investing.com

Aug 08, 2025
pulisher
Aug 08, 2025

Cidara Therapeutics: Q2 Earnings Snapshot - Manistee News Advocate

Aug 08, 2025
pulisher
Aug 08, 2025

Cidara Therapeutics stock price target raised to $66 at Citizens JMP - Investing.com Australia

Aug 08, 2025
pulisher
Aug 08, 2025

Cidara Therapeutics Inc (CDTX) Q2 2025 Earnings Call Highlights: Promising Clinical Trial ... - Yahoo Finance

Aug 08, 2025
pulisher
Aug 08, 2025

Cidara Therapeutics Inc (CDTX) Q2 2025 Earnings Call Highlights: Promising Clinical Trial ... By GuruFocus - Investing.com Canada

Aug 08, 2025
pulisher
Aug 07, 2025

Cidara Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 07, 2025
pulisher
Aug 07, 2025

Cidara Therapeutics 2024 Q2 Earnings Deepened Losses Amid Strong Clinical Progress - AInvest

Aug 07, 2025
pulisher
Aug 07, 2025

Transcript : Cidara Therapeutics, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener

Aug 07, 2025
pulisher
Aug 07, 2025

Cidara Therapeutics reports Q2 EPS ($1.65), consensus ($1.82) - TipRanks

Aug 07, 2025
pulisher
Aug 07, 2025

Cidara Therapeutics Q2 net loss narrows - MarketScreener

Aug 07, 2025
pulisher
Aug 07, 2025

Cidara Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results - GlobeNewswire

Aug 07, 2025
pulisher
Aug 07, 2025

Spero leads infectious disease gains with 252% stock jump - BioWorld MedTech

Aug 07, 2025
pulisher
Aug 06, 2025

RBC Capital raises Cidara Therapeutics stock price target to $115 on market potential - Investing.com Canada

Aug 06, 2025
pulisher
Aug 06, 2025

Cidara Therapeutics price target raised to $115 from $75 at RBC Capital - TipRanks

Aug 06, 2025
pulisher
Aug 05, 2025

Cidara Therapeutics Inc expected to post a loss of $2.00 a shareEarnings Preview - TradingView

Aug 05, 2025
pulisher
Aug 05, 2025

Cidara Therapeutics CDTX Q2 2025 Earnings Preview Upside Potential on Analyst Optimism - AInvest

Aug 05, 2025
pulisher
Aug 03, 2025

Is Cidara Therapeutics Inc. stock overvalued or undervaluedCapitalize on market momentum for maximum gains - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Should I hold or sell Cidara Therapeutics Inc. stock in 2025Achieve breakthrough gains with expert advice - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Cidara Therapeutics Inc. Stock Analysis and ForecastInvest smarter with data-backed insights - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How strong is Cidara Therapeutics Inc. company’s balance sheetGet daily updates on promising stocks - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What institutional investors are buying Cidara Therapeutics Inc. stockBuild a diversified portfolio for risk management - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What makes Cidara Therapeutics Inc. stock price move sharplyRecord-breaking capital gains - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is Cidara Therapeutics Inc. a good long term investmentInvest with confidence backed by data - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are analysts’ price targets for Cidara Therapeutics Inc. in the next 12 monthsDynamic portfolio growth - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is the risk reward ratio of investing in Cidara Therapeutics Inc. stockAchieve rapid wealth accumulation through smart investing - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

What is the dividend policy of Cidara Therapeutics Inc. stockFree Trading Psychology Coaching - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What are Cidara Therapeutics Inc. company’s key revenue driversAchieve rapid capital gains with smart investing - Jammu Links News

Aug 02, 2025
pulisher
Aug 01, 2025

Will Cidara Therapeutics Inc. Bounce From 52 Week LowTriple Digit Growth Focused Trade Plan Reviewed - metal.it

Aug 01, 2025
pulisher
Jul 30, 2025

Moving Average Crossover Confirms Uptrend in Cidara Therapeutics Inc.Real Time Alerts Based on AI Prediction Triggered - metal.it

Jul 30, 2025
pulisher
Jul 30, 2025

How Cidara Therapeutics Inc. stock performs during market volatilityHigh Win Rate Trading Opportunities Detected - beatles.ru

Jul 30, 2025
pulisher
Jul 30, 2025

Can trapped investors hope for a rebound in Cidara Therapeutics Inc.Real-Time Trade Insights Spark Market Reactions - metal.it

Jul 30, 2025
pulisher
Jul 29, 2025

Will Cidara Therapeutics Inc. stock split in the near futureInvestment Strategy With Predictable Gains Outlined - metal.it

Jul 29, 2025

Cidara Therapeutics Inc Azioni (CDTX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$36.35
price down icon 0.41%
$86.92
price up icon 0.88%
$26.69
price up icon 0.91%
$127.80
price up icon 0.04%
$113.52
price up icon 0.73%
biotechnology ONC
$321.36
price up icon 3.77%
Capitalizzazione:     |  Volume (24 ore):